Gyon Technologies Capital Management, LP Otonomy, Inc. Transaction History

Gyon Technologies Capital Management, LP

  • $0
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$2.49 - $6.23 $116,175 - $290,673
-46,657 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$3.48 - $6.47 $57,159 - $106,269
16,425 Added 54.33%
46,657 $302,000
Q3 2020

Nov 16, 2020
BUY
$3.16 - $4.36 $42,729 - $58,955
13,522 Added 80.92%
30,232 $122,000
Q2 2020

Aug 14, 2020
BUY
$1.87 - $3.84 $31,247 - $64,166
16,710 New
16,710 $60,000

About OTONOMY, INC.

OTIC Quotes by TradingView
  • Ticker OTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,990,400
  • Description
  • Otonomy, Inc., a biopharmaceutical company, develops therapeutics for neurotology in the United States. The company offers OTO-313, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in Phase II clinical trials to treat tinnitus; and OTO-413, a sustained-exposure formulation of brain-derived neurot...
More about OTIC
Track This Portfolio

Track Gyon Technologies Capital Management, LP Portfolio

Follow Gyon Technologies Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email